(Q37234005)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Carsten Hopf

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

2

Marcus Bantscheff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1

Ulrich Kruse

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

Molecular & Cellular Proteomics

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1887-1901

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

The blood peptidome: a higher dimension of information content for cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Defective downregulation of receptor tyrosine kinases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Pathway proteomics and chemical proteomics team up in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Proteomics in clinical trials and practice: present uses and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Graded regulation of the Kv2.1 potassium channel by variable phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Fractionation of isotopically labeled peptides in quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Top-down quantitation and characterization of SILAC-labeled proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Absolute SILAC for accurate quantitation of proteins in complex mixtures down to the attomole level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Unique scanning capabilities of a new hybrid linear ion trap mass spectrometer (Q TRAP) used for high sensitivity proteomics applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Higher-energy C-trap dissociation for peptide modification analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

iTRAQ reagent-based quantitative proteomic analysis on a linear ion trap mass spectrometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Advances in the analysis of protein phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Integrated analytical strategies for the study of phosphorylation and glycosylation in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Phosphoproteomic analysis of the developing mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Large-scale characterization of HeLa cell nuclear phosphoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Large-scale phosphorylation analysis of mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Phosphoproteome analysis of Drosophila melanogaster embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Highly robust, automated, and sensitive online TiO2-based phosphoproteomics applied to study endogenous phosphorylation in Drosophila melanogaster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Signal transduction by growth factor receptors: signaling in an instant

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Dissection of the insulin signaling pathway via quantitative phosphoproteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Immunoaffinity profiling of tyrosine phosphorylation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Identification of the ligands of protein interaction domains through a functional approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

High-throughput phosphotyrosine profiling using SH2 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

A probability-based approach for high-throughput protein phosphorylation analysis and site localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

The utility of ETD mass spectrometry in proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Phosphoproteomic Analysis of the Mouse Brain Cytosol Reveals a Predominance of Protein Phosphorylation in Regions of Intrinsic Sequence Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Analysis of phosphorylation sites on focal adhesion kinase using nanospray liquid chromatography/multiple reaction monitoring mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Chemoproteomics-driven drug discovery: addressing high attrition rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

From magic bullets to designed multiple ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Phosphoinositide 3-kinases as drug targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Issues and progress with protein kinase inhibitors for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Histone deacetylase inhibitors: biology and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Multiple-target drugs: inhibitors of heat shock protein 90 and of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Heat-shock protein 90 inhibitors as novel cancer chemotherapeutics - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Can we rationally design promiscuous drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Cancer cell-based genomic and small molecule screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Analysis of drug-induced effect patterns to link structure and side effects of medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Characterisation of kinase-selective inhibitors by chemical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

On the iTRAQ of kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Tagging and detection strategies for activity-based proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Activity-based protein profiling: from enzyme chemistry to proteomic chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

The purinome, a complex mix of drug and toxicity targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Discovery of novel targets of quinoline drugs in the human purine binding proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Activity-based probes that target diverse cysteine protease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Activity-based probes for proteomic profiling of histone deacetylase complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Discovering potent and selective reversible inhibitors of enzymes in complex proteomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Functional interrogation of the kinome using nucleotide acyl phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Clinical development of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors: what lessons have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative mass spectrometry in proteomics: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Differential expression of novel tyrosine kinase substrates during breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Tyrosine phosphoproteomics of fibroblast growth factor signaling: a role for insulin receptor substrate-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Structural bioinformatics-based design of selective, irreversible kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Regulation of the c-Abl and Bcr-Abl tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

A common phosphotyrosine signature for the Bcr-Abl kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative proteomic analysis of post-translational modifications of human histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Update on epidermal growth factor receptor mutations in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Signaling networks assembled by oncogenic EGFR and c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Affinity separation and enrichment methods in proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Affinity as a tool in life science

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Activity-based protein profiling for the functional annotation of enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Experimental and computational approaches to quantitative proteomics: status quo and outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

HPLC techniques for proteomics analysis--a short overview of latest developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Multidimensional separations-based shotgun proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Highly efficient peptide separations in proteomics Part 1. Unidimensional high performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Accessible proteomics space and its implications for peak capacity for zero-, one- and two-dimensional separations coupled with FT-ICR and TOF mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

High-throughput proteomics of breast carcinoma cells: a focus on FTICR-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Mass spectrometry-based proteomics turns quantitative

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Developing liquid chromatography ion mobility mass spectometry techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Ion mobility-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Accurate mass measurements in proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Analysis and validation of proteomic data generated by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Methods, algorithms and tools in computational proteomics: a practical point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative proteomics using stable isotope labeling with amino acids in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Accurate quantitation of protein expression and site-specific phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Protease-catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix-assisted laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

A model for random sampling and estimation of relative protein abundance in shotgun proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Profiling of UV-induced ATM/ATR signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Chemical proteomics identifies unanticipated targets of clinical kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Reproducible isolation of distinct, overlapping segments of the phosphoproteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Multiple Reaction Monitoring to Identify Sites of Protein Phosphorylation with High Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Fast LC separation of a myoglobin digest: a case study using monolithic and particulate RP 18 silica capillary columns

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Protein labeling by iTRAQ: A new tool for quantitative mass spectrometry in proteome research

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

Quantitative proteomic assessment of very early cellular signaling events

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.R800006-MCP200

10.1074/MCP.R800006-MCP200

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18676365%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference